Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.
Leading players operating in the PCR for Respiratory Infection Diagnostics Market adopt various growth strategies, such as product launches, approvals, partnerships, and business planning. These strategies help them expand their business in the global market. The market majorly consists of the players such as Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc., BD, AusDiagnostics, Seegene Inc., Abbott, Qiagen, bioMérieux, and Hologic Inc. are among the leading companies operating in the pcr for respiratory infection diagnostics market.
BD, and Bio-Rad Laboratories Inc. — Notable Market Players in PCR for Respiratory Infection Diagnostics Market
Companies such as Thermo Fisher Scientific Inc, AusDiagnostics, Qiagen, BD, Bio-Rad Laboratories Inc, Seegene Inc., Abbott, and Hologic Inc. have been implementing various strategies that have propelled the growth of the company, which, in turn, have brought various changes in the PCR for Respiratory Infection Diagnostics Market.
A few growth strategies done by the players operating in the pcr for respiratory infection diagnostics market are listed below:
| Month & Year | Description |
| June-2021 | USA Swimming, the national governing body for the sport of swimming in the United States, and BD (Becton, Dickinson and Company) a leading global medical technology company, have partnered to provide COVID-19 testing at USA Swimming events.. |
| Apr-2021 | USA Track & Field (USATF) and BD (Becton, Dickinson and Company) a leading global medical technology company, have partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets to help get USATF professional athletes back to competition safely through the use of the BD Veritor Plus system. |
| Feb-2021 | Thermo Fisher Scientific Inc. the world leader in serving science, announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. |
| Apr-2021 | Bio-Rad Laboratories, Inc. announced the release of the The real-time reverse-transcription PCR (RT-PCR) assay kit can detect nucleic acid in SARS-CoV-2, the virus associated with COVID-19 disease. |
| Nov-2020 | BD (Becton, Dickinson and Company) a leading global medical technology company, announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management |
| Oct-2020 | bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfolio to African Union Member States |
| Nov-2020 | QIAreach SARS-CoV-2 Antigen Test, developed in partnership with Ellume, is an important step towards decentralized mass screening by processing samples in 2–15 minutes |
| Sep-2020 | QIAGEN announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. |
| Oct-2020 | Bio-Rad Laboratories, Inc. announced the release the next generation of Bio-Rad’s CFX Real-time PCR products that are used in research and genomic testing as well pathogen detection and infectious disease testing. |
| Nov-2019 | Bio-Rad Laboratories, Inc. announced the release of its QX ONE Droplet Digital PCR System to early access customers at the Association for Molecular Pathology (AMP) Meeting & Expo in Baltimore. |
